ARCHIVES

FDA Backs Down, Releases INDs, But Revives Controversy Over Clinical Testing Guidelines

This article is from The Cancer Letter archive.

Vol. 02 No. 11 | March 12, 1976

Download PDF Visit The Full Archive

Related Articles

Review Panel: NCI Intramural Program Is Too Large, Redundant, Hierarchical

May 19, 1995

Tamoxifen Trial Enrolls 19% Of Women Needed, Fisher Reports To NCAB

October 16, 1992

Funding Opportunities: Lustgarten Foundation Request For Proposals; RFAs Available; NCI Grant Supplements.

June 20, 2003

NHGRI Director Francis Collins To Step Down.

May 30, 2008

In Brief: Hawaii Center Searching For New Director: Rosenberg Denies Report He’s Going To Tampa

June 7, 1985

Ohio State Breaks Ground For $1 Billion Expansion Of Medical Center, Cancer Hospital

June 18, 2010